IMMULITE 2000 assays are designed for use with the IMMULITE 2000, a high-throughput, continuous random access immunoassay analyzer. IMMULITE 2000 offers testing efficiency through centralization, and
...EIATM IGF-I kit is a two-site ELISA for the quanti...-I (IGF-I) in serum or plasma. The assay uses a hi...rotiter wells and a high affinity monoclonal antib... sample pre-treatment replaces acid/ethanol extrac...
For The Detection Of Serum C-Peptide Levels.,Clinical Uses Of C-Peptide Measurement:, Evaluating patients with fasting hypoglycemia , Assisting in the classification of diabetes mellitus , D
... IR Excimer Laser System is designed to bring Cust...ife and provide the flexibility to treat patients ..., ,Technologies like Active Trak 3-D eye track...VSS), Variable Repetition Rate (VRR), and Iris Reg...
Medicine Products:(Date:11/21/2008)... technique to combat cancer, study says, , ...n researchers have discovered that some cancer cel...this might lead to new treatments that starve and ... all cells in the body need to produce energy. The...at requires oxygen. Compared with normal cells, tu...
(Date:11/21/2008)... NursingCenter.com, the premier site,for online n...ent, has been,updated to improve the interactive ...red by Lippincott Williams & Wilkins (LWW), Nu...ed continuing education activities and free,acces...sing journals.,Lippincott Williams & Wilkins ...
(Date:11/21/2008)... general membership of the Medical,Advertising Ha...t their Annual,Awards Dinner to be held February ...ime Achievement Award will also be given. , ...all of Fame are: , Ronald Pantello, who began h... Sudler & Hennessey. In 1980 he left Sudler &a...
(Date:11/21/2008)...use genetic damage that can lead to disease , ...pular medications for treating attention-deficit h...damage linked to an increased risk for developing ...researchers at Duke University Medical Center and ...ious one that reported biomarkers associated with ...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2(Date:11/19/2008)...THOUSAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCa...e Takeda Oncology Company, a subsidiary of,Takeda... announced that,enrollment in the Phase 3 MONET1 ...on with paclitaxel and carboplatin for the first-l...cer (NSCLC) has been temporarily suspended,follow...
(Date:11/19/2008)...-Triggers $5 Million Payment from Roche- , , ...- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) t... goal for its Phase 2 trial of R3487/MEM 3454, its...tive impairment associated with schizophrenia (CIA...e Phase 2 trial, triggering a $5.0 million payment...
(Date:11/18/2008)...American Lung Association,s 2008 Faces of Influenz...lies immunized against influenza; Mother and Gold ..., WASHINGTON, Nov. 18 While 78 ...nfluenza a severe and potentially life-threatening...is likely their families will get vaccinated this ...
(Date:11/12/2008)... NEW YORK, Nov. 12 A... edition of Cell will help answer the,question, wh...ressing questions in the medical research into,Par...s in the brain to die,in the first place. Answerin...use there are two nearly identical types of brain ...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Antares Management Solutions Selects Hyland Softwares OnBase 13993 1Antares Management Solutions Selects Hyland Softwares OnBase 13993 2Schering Plough Announces Filing of U S Application for OTC ZEGERID 28R 29 3853 1Schering Plough Announces Filing of U S Application for OTC ZEGERID 28R 29 3853 2Schering Plough Announces Filing of U S Application for OTC ZEGERID 28R 29 3853 3Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 1Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 2Totality of Available Data Reaffirms PROCRIT 28R 29 28Epoetin alfa 29 Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy 1495 1Totality of Available Data Reaffirms PROCRIT 28R 29 28Epoetin alfa 29 Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy 1495 2Totality of Available Data Reaffirms PROCRIT 28R 29 28Epoetin alfa 29 Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy 1495 3Totality of Available Data Reaffirms PROCRIT 28R 29 28Epoetin alfa 29 Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy 1495 4Totality of Available Data Reaffirms PROCRIT 28R 29 28Epoetin alfa 29 Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy 1495 5Totality of Available Data Reaffirms PROCRIT 28R 29 28Epoetin alfa 29 Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy 1495 6...tion highlights health care cost benefit of,bioeng...swire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) ...eeting of the American Society of Clinical Oncolog... utilization (MRU) and,associated costs with XYOTA...mcitabine or vinorelbine in treating patients with...
...lif.--(BUSINESS WIRE)--Jun 4, 2007 - Researchers a...illuminated the path,taken by human neural stem ce... and mice, and found that the cells successfully,n...rch group placed miniscule particles of iron insid...y magnetic,resonance imaging. With the ability to ...
Other Medicine Technology:XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine,or Vinorelbine in Treating Non-Small Cell Lung Cancer 2XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine,or Vinorelbine in Treating Non-Small Cell Lung Cancer 3XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine,or Vinorelbine in Treating Non-Small Cell Lung Cancer 4Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 2Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 3Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 4